225 related articles for article (PubMed ID: 32973273)
1. Glucocorticoid-induced cell-derived matrix modulates transforming growth factor β2 signaling in human trabecular meshwork cells.
Yemanyi F; Vranka J; Raghunathan VK
Sci Rep; 2020 Sep; 10(1):15641. PubMed ID: 32973273
[TBL] [Abstract][Full Text] [Related]
2. Effects of Toll-Like Receptor 4 Inhibition on Transforming Growth Factor-β2 Signaling in the Human Trabecular Meshwork.
Sharma TP; Curry S; McDowell CM
J Ocul Pharmacol Ther; 2020 Apr; 36(3):170-178. PubMed ID: 31834824
[No Abstract] [Full Text] [Related]
3. Gremlin utilizes canonical and non-canonical TGFβ signaling to induce lysyl oxidase (LOX) genes in human trabecular meshwork cells.
Sethi A; Wordinger RJ; Clark AF
Exp Eye Res; 2013 Aug; 113():117-27. PubMed ID: 23748100
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension.
Kasetti RB; Maddineni P; Patel PD; Searby C; Sheffield VC; Zode GS
J Biol Chem; 2018 Jun; 293(25):9854-9868. PubMed ID: 29743238
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells.
Tovar-Vidales T; Clark AF; Wordinger RJ
Exp Eye Res; 2011 Oct; 93(4):442-51. PubMed ID: 21722634
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-2 is up-regulated by TGFβ2 and increases fibronectin expression in human trabecular meshwork cells.
Kennedy SM; Sheridan C; Kearns VR; Bilir EK; Fan X; Grierson I; Choudhary A
Exp Eye Res; 2019 Dec; 189():107820. PubMed ID: 31589839
[TBL] [Abstract][Full Text] [Related]
7. Role of TGFbeta/Smad signaling in gremlin induction of human trabecular meshwork extracellular matrix proteins.
Sethi A; Jain A; Zode GS; Wordinger RJ; Clark AF
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5251-9. PubMed ID: 21642622
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue growth factor induces extracellular matrix deposition in human trabecular meshwork cells.
Junglas B; Yu AH; Welge-Lüssen U; Tamm ER; Fuchshofer R
Exp Eye Res; 2009 Jun; 88(6):1065-75. PubMed ID: 19450452
[TBL] [Abstract][Full Text] [Related]
9. BMP and Activin Membrane Bound Inhibitor Regulates the Extracellular Matrix in the Trabecular Meshwork.
Hernandez H; Millar JC; Curry SM; Clark AF; McDowell CM
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):2154-2166. PubMed ID: 29801150
[TBL] [Abstract][Full Text] [Related]
10. Paeoniflorin alleviates TGF-β2-mediated extracellular matrix remodeling and oxidative stress in human trabecular meshwork cells.
Hu Y; Ge K; Du Y
Int Ophthalmol; 2024 May; 44(1):229. PubMed ID: 38795168
[TBL] [Abstract][Full Text] [Related]
11. TGF-β2-induced invadosomes in human trabecular meshwork cells.
Han H; Kampik D; Grehn F; Schlunck G
PLoS One; 2013; 8(8):e70595. PubMed ID: 23940598
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling.
Fuchshofer R; Stephan DA; Russell P; Tamm ER
Exp Eye Res; 2009 Jun; 88(6):1020-32. PubMed ID: 19450457
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells.
Fuchshofer R; Yu AH; Welge-Lüssen U; Tamm ER
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):715-26. PubMed ID: 17251470
[TBL] [Abstract][Full Text] [Related]
14. TGFβ2 Regulates Human Trabecular Meshwork Cell Contractility
Li H; Henty-Ridilla JL; Bernstein AM; Ganapathy PS; Herberg S
Curr Eye Res; 2022 Aug; 47(8):1165-1178. PubMed ID: 35481448
[TBL] [Abstract][Full Text] [Related]
15. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure.
Fleenor DL; Shepard AR; Hellberg PE; Jacobson N; Pang IH; Clark AF
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):226-34. PubMed ID: 16384967
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-kappa beta signaling is required for transforming growth factor Beta-2 induced ocular hypertension.
Hernandez H; Roberts AL; McDowell CM
Exp Eye Res; 2020 Feb; 191():107920. PubMed ID: 31923415
[TBL] [Abstract][Full Text] [Related]
17. Silibinin attenuates TGF-β2-induced fibrogenic changes in human trabecular meshwork cells by targeting JAK2/STAT3 and PI3K/AKT signaling pathways.
Wu X; Liang J; Liu J; Huang Y; Zhang L; Liu X; Guo J; Zhang M; Chen Y; Wang J
Exp Eye Res; 2024 Jul; 244():109939. PubMed ID: 38789021
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial-Targeted Antioxidants Attenuate TGF-β2 Signaling in Human Trabecular Meshwork Cells.
Rao VR; Lautz JD; Kaja S; Foecking EM; Lukács E; Stubbs EB
Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3613-3624. PubMed ID: 31433458
[TBL] [Abstract][Full Text] [Related]
19. TGFβ2 Induces the Formation of Cross-Linked Actin Networks (CLANs) in Human Trabecular Meshwork Cells Through the Smad and Non-Smad Dependent Pathways.
Montecchi-Palmer M; Bermudez JY; Webber HC; Patel GC; Clark AF; Mao W
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1288-1295. PubMed ID: 28241317
[TBL] [Abstract][Full Text] [Related]
20. TGFβ2-induced outflow alterations in a bioengineered trabecular meshwork are offset by a rho-associated kinase inhibitor.
Torrejon KY; Papke EL; Halman JR; Bergkvist M; Danias J; Sharfstein ST; Xie Y
Sci Rep; 2016 Dec; 6():38319. PubMed ID: 27924833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]